Close Menu

NEW YORK – The US Food and Drug Administration on Wednesday provided Emergency Use Authorization to Stanford Health Care Clinical Virology Laboratory's SARS-CoV-2 assay.

The Stanford SARS-CoV-2 assay is a real-time RT-PCR test for detecting SARS-CoV-2 in nasopharyngeal, oropharyngeal, nasal, and mid-turbinate nasal swabs and bronchoalveolar lavage fluid. It runs on the Qiagen Rotor-Gene Q thermocycler, and RNA can be extracted using the Qiagen EZ1 XL or QIAsymphony SP/AS extraction platforms. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.